Zyprexa Intramuscular recalled over manufacturing violations
- Recall date
- June 29, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Eli Lilly & Company recalls Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, India…
- Recall number
- D-0720-2021
- FDA classification
- Class II
- Brand / firm
- Eli Lilly & Company
- Sold / distributed
- OH, MS, IN
Why it was recalled
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Get recall alerts
Free email alert whenever Eli Lilly & Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Eli Lilly & Company